Strikingly, a decreased IL-6 serum level was observed in healthy individuals and patients with a single nucleotide polymorphism in the promotor region of the IL-6 gene, IL-6-572C/G, which correlated with decreased risk to develop IPAH (97). The gene discussed is IL6; the disease is idiopathic pulmonary arterial hypertension.